This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: ETH Zurich, Unversität Zürich. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 555 
1 out of 276 
Years Active: 2022
Title: Florian Nils Rosenthal: Innovator in Microbiome Therapeutics
Introduction
Florian Nils Rosenthal is an accomplished inventor based in Zurich, Switzerland, recognized for his innovative contributions to the field of microbiome therapeutics. With a keen focus on the treatment of microbiome dysbiosis, Rosenthal has made significant strides in developing novel bacterial compositions for pharmaceutical applications.
Latest Patents
Rosenthal holds a patent titled "Consortia of Living Bacteria Useful for Treatment of Microbiome Dysbiosis." This innovative invention encompasses unique compositions that include specific consortia of living bacterial strains aimed at addressing diseases linked to intestinal microbiota dysbiosis. The patent describes a manufacturing process that emphasizes co-cultivation of these bacterial strains. Notably, the compositions demonstrate greater efficacy and safety compared to traditional Fecal Microbiota Transplantation (FMT) therapy, particularly in treating conditions like Clostridium difficile infection (CDI) and Inflammatory Bowel Diseases (IBD), as validated by testing on acute colitis models.
Career Highlights
Florian Rosenthal has spent a considerable part of his career at prestigious institutions such as ETH Zurich and the University of Zurich. His research work has led to groundbreaking developments in the applications of microbiota therapy and has positioned him as a thought leader in this emerging discipline. His commitment to innovation in medicine continues to inspire ongoing research in the treatment of complex gastrointestinal disorders.
Collaborations
Throughout his career, Rosenthal has collaborated with esteemed colleagues such as Christophe Lacroix and Tomas De Wouters. These partnerships have contributed to the advancement of knowledge in the field and have facilitated the successful development of his patent.
Conclusion
Florian Nils Rosenthal exemplifies the spirit of innovation within the realm of microbiome research. His work not only contributes to scientific advancement but also holds promise for improved therapeutic solutions for individuals suffering from debilitating intestinal conditions. As the field of microbiome therapeutics evolves, inventors like Rosenthal play a crucial role in shaping its future.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile